Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2
Michael D. Grant, Kirsten Bentley, Ceri A. Fielding, et al.
JCI Insight (2023) Vol. 8, Iss. 15
Open Access | Times Cited: 13

Showing 13 citing articles:

Recombinant protein HR212 targeting heptad repeat 2 domain in spike protein S2 subunit elicits broad‐spectrum neutralizing antibodies against SARS‐CoV‐2 and its variants
Ying Lu, An‐Qi Li, Fan Shen, et al.
MedComm (2025) Vol. 6, Iss. 2
Open Access | Times Cited: 1
Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants
Luyi Chen, Ying He, Hongye Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
Tetsuya Inoue, Yuichiro Yamamoto, Kaoru Sato, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109363-109363
Open Access | Times Cited: 5
The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2
Jamie Guenthoer, Meghan Garrett, Michelle M. Lilly, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012383-e1012383
Open Access | Times Cited: 5
Navigating the Unknown: Open Questions Surrounding Natural Killer Cell Responses to SARS-CoV-2
Quirin Hammer
Springer eBooks (2025), pp. 1-21
Closed Access
Identification of soluble biomarkers that associate with distinct manifestations of long COVID
Yu Gao, Curtis Cai, Sarah Adamo, et al.
Nature Immunology (2025) Vol. 26, Iss. 5, pp. 692-705
Open Access
From natural defenders to therapeutic warriors: NK cells in HIV immunotherapy
Thessa Laeremans, A Janssens, Joeri L. Aerts
Immunotherapy (2025), pp. 1-13
Closed Access
High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1
William Bolland, Vincent Michel, Delphine Planas, et al.
Journal of Virology (2023) Vol. 98, Iss. 1
Open Access | Times Cited: 8
Vaccine-elicited immune pressure and SARS-CoV-2 mutational dynamics in breakthrough infections
Sarwareddy Kartik Kumar, Srinivas Sathrasala, Jandhyala Sai Krishna, et al.
Gene Reports (2024) Vol. 35, pp. 101899-101899
Closed Access | Times Cited: 1
Characteristics of Vaccine- and Infection-Induced Systemic IgA Anti-SARS-CoV-2 Spike Responses
Natasha J. Norton, Danielle P. Ings, Kathleen E. Fifield, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1462-1462
Open Access | Times Cited: 3
The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2
Jamie Guenthoer, Meghan Garrett, Michelle M. Lilly, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
SARS-CoV-2 Vaccine-Elicited Immunity after B Cell Depletion in Multiple Sclerosis
Ryan M. Baxter, Berenice Cabrera-Martinez, Tusharkanti Ghosh, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 3, pp. 254-268
Open Access
Identification of soluble biomarkers that associate with distinct manifestations of long COVID
Marcus Buggert, Yu Gao, Curtis Cai, et al.
Research Square (Research Square) (2024)
Open Access
Coronaviruses: Pandemic SARS-CoV-2
Benjamin J. Cowling, Sook‐San Wong
Springer eBooks (2024), pp. 1-79
Closed Access
Page 1

Scroll to top